News
TMDX
115.01
-0.47%
-0.54
Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks
Benzinga · 1d ago
Canaccord Genuity Sticks to Its Buy Rating for TransMedics Group (TMDX)
TipRanks · 3d ago
TransMedics Group (TMDX) Receives a Buy from Piper Sandler
TipRanks · 4d ago
Weekly Report: what happened at TMDX last week (1103-1107)?
Weekly Report · 4d ago
Polen U.S. Small Cap Growth Q3 2025 Portfolio Performance And Attribution
Seeking Alpha · 11/06 08:50
Evercore ISI’s ‘Tactical, Action, Position’ list of ideas
Seeking Alpha · 11/04 18:05
Oppenheimer Remains a Buy on TransMedics Group (TMDX)
TipRanks · 11/03 16:57
Weekly Report: what happened at TMDX last week (1027-1031)?
Weekly Report · 11/03 09:55
TransMedics Director Edward M. Basile Reports Disposal of Common Shares
Reuters · 10/31 20:30
TransMedics Grants Stock Options and RSUs to New Employees as Hiring Incentive
Reuters · 10/31 20:05
TRANSMEDICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 10/31 20:05
TransMedics: Growth Tailwinds Should Provide Upside In 2026
Seeking Alpha · 10/31 15:54
TransMedics Group’s Earnings Call Highlights Robust Growth and Strategic Expansion
TipRanks · 10/31 00:36
TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
NASDAQ · 10/30 17:56
BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna
Reuters · 10/30 17:41
TransMedics: Q3 Results Disappointed, As Expected (Rating Upgrade)
Seeking Alpha · 10/30 15:23
TransMedics Group Is Maintained at Buy by Canaccord Genuity
Dow Jones · 10/30 14:17
TransMedics Group Price Target Raised to $147.00/Share From $142.00 by Canaccord Genuity
Dow Jones · 10/30 14:17
Canaccord Genuity Maintains Buy on TransMedics Group, Raises Price Target to $147
Benzinga · 10/30 14:07
TransMedics Group Price Target Cut to $140.00/Share From $145.00 by Piper Sandler
Dow Jones · 10/30 13:52
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.